Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PE Biosystems (PEB) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (17)	1/28/1998 11:25:00 AM
From: PuddleGlum	Read Replies (1) \| Respond to of 122

Richard- I'm not surprised by the slight shortfall in earnings, but I was disappointed in the business summary and outlook for the coming year. As someone noted on the Yahoo thread, this stock has just completed a head-and-shoulders top, which would project a price target of $40 or thereabouts. Not too encouraging. On the bright side, most of the company's customers, even when considering analytical instruments, are pharma and biotech, so the fundamental position is sound. I'd be inclined (until further notice, at least) to award this company a p/e ratio of 20 or less, which means that the upside for the next year is probably around $75. Steve